Automated brightfield morphometry of 3D organoid populations by OrganoSeg MA Borten, SS Bajikar, N Sasaki, H Clevers, KA Janes Scientific reports 8 (1), 5319, 2018 | 116 | 2018 |
Tumor-suppressor inactivation of GDF11 occurs by precursor sequestration in triple-negative breast cancer SS Bajikar, CC Wang, MA Borten, EJ Pereira, KA Atkins, KA Janes Developmental cell 43 (4), 418-435. e13, 2017 | 79 | 2017 |
A time-and matrix-dependent TGFBR3–JUND–KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies CC Wang, SS Bajikar, L Jamal, KA Atkins, KA Janes Nature cell biology 16 (4), 345-356, 2014 | 79 | 2014 |
Parameterizing cell-to-cell regulatory heterogeneities via stochastic transcriptional profiles SS Bajikar, C Fuchs, A Roller, FJ Theis, KA Janes Proceedings of the National Academy of Sciences 111 (5), E626-E635, 2014 | 52 | 2014 |
Disruption of MeCP2–TCF20 complex underlies distinct neurodevelopmental disorders J Zhou, H Hamdan, HK Yalamanchili, K Pang, AE Pohodich, J Lopez, ... Proceedings of the National Academy of Sciences 119 (4), e2119078119, 2022 | 42 | 2022 |
Antisense oligonucleotide therapy in a humanized mouse model of MECP2 duplication syndrome Y Shao, Y Sztainberg, Q Wang, SS Bajikar, AJ Trostle, YW Wan, ... Science translational medicine 13 (583), eaaz7785, 2021 | 30 | 2021 |
Multiscale models of cell signaling SS Bajikar, KA Janes Annals of biomedical engineering 40, 2319-2327, 2012 | 26 | 2012 |
Bone Marrow–Derived Cell-Specific Chemokine (CC Motif) Receptor-2 Expression is Required for Arteriolar Remodeling MM Nickerson, J Song, JK Meisner, S Bajikar, CW Burke, CW Shuptrine, ... Arteriosclerosis, thrombosis, and vascular biology 29 (11), 1794-1801, 2009 | 19 | 2009 |
Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11 TA Ravenscroft, JB Phillips, E Fieg, SS Bajikar, J Peirce, J Wegner, ... Genetics in Medicine 23 (10), 1889-1900, 2021 | 14 | 2021 |
Identification and characterization of conserved noncoding cis-regulatory elements that impact Mecp2 expression and neurological functions Y Shao, SS Bajikar, HP Tirumala, MC Gutierrez, JD Wythe, HY Zoghbi Genes & Development 35 (7-8), 489-494, 2021 | 6 | 2021 |
MeCP2 regulates Gdf11, a dosage-sensitive gene critical for neurological function SS Bajikar, AG Anderson, J Zhou, MA Durham, AJ Trostle, YW Wan, Z Liu, ... Elife 12, e83806, 2023 | 4 | 2023 |
A novel pathogenic mutation of MeCP2 impairs chromatin association independent of protein levels J Zhou, C Cattoglio, Y Shao, HP Tirumala, C Vetralla, SS Bajikar, Y Li, ... Genes & Development 37 (19-20), 883-900, 2023 | 2 | 2023 |
Advanced Molecular Studies Resolving the Genomic Structure in MECP2 Duplication Syndrome Informs the Genotype-Phenotype Correlations and Potential Interventions D Pehlivan, M Gandhi, CM Grochowski, SS Bajikar, HK Harris, B Suter, ... ANNALS OF NEUROLOGY 92, S171-S172, 2022 | | 2022 |
Parameterizing cell-to-cell regulatory heterogeneities via stochastic transcriptional profiles K Janes, S Bajikar, F Theis, C Fuchs US Patent 10,453,555, 2019 | | 2019 |